Outcome of patients with intracranial relapse enrolled on national Wilms Tumor Study Group clinical trials.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28097788)

Published in Pediatr Blood Cancer on January 18, 2017

Authors

Rajkumar Venkatramani1, Yueh-Yun Chi2, Max J Coppes3, Marcio Malogolowkin4, John A Kalapurakal5, Jing Tian2, Jeffrey S Dome6

Author Affiliations

1: Rare Tumors Program, Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas.
2: Department of Biostatistics, University of Florida, Gainesville, Florida.
3: Renown Health, Reno, Nevada.
4: University of California Davis Comprehensive Cancer Center, Sacramento, California.
5: Luire Children's Hospital Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
6: Children's National Medical Center, Washington, District of Columbia.

Articles cited by this

Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer (1989) 4.34

Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol (1998) 3.53

The treatment of Wilms' tumor: Results of the national Wilms' tumor study. Cancer (1976) 2.80

The treatment of Wilms' tumor: results of the Second National Wilms' Tumor Study. Cancer (1981) 2.43

Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. J Clin Oncol (2006) 2.15

Prognostic factors for children with recurrent Wilms' tumor: results from the Second and Third National Wilms' Tumor Study. J Clin Oncol (1989) 1.40

Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer (2008) 1.11

Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol (1994) 1.11

Twenty-five year follow-up of childhood Wilms tumor: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer (2011) 1.09

Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group. Pediatr Blood Cancer (2007) 1.05

Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: a report of the SIOP renal tumour study group. Pediatr Blood Cancer (2010) 0.97

Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration. J Clin Oncol (2015) 0.93

Treatment of recurrent clear cell sarcoma of the kidney with brain metastasis. Pediatr Blood Cancer (2008) 0.93

An international strategy to determine the role of high dose therapy in recurrent Wilms' tumour. Eur J Cancer (2012) 0.93

Outcome of relapses of nephroblastoma in patients registered in the SIOP/GPOH trials and studies. Oncol Rep (2008) 0.92

Brain metastases in children with solid tumors. Cancer (1997) 0.87

Treatment and outcome of patients with relapsed clear cell sarcoma of the kidney: a combined SIOP and AIEOP study. Br J Cancer (2014) 0.84

Central nervous system metastasis in Wilms' tumor: a review of three consecutive United Kingdom trials. Cancer (1998) 0.82

Survival following brain metastases in wilms' tumor. Pediatrics (1976) 0.81

Intracranial relapse in Wilms tumor patients. Pediatr Blood Cancer (2004) 0.78

Successful treatment of Wilms' tumor with intracranial metastases. Pediatrics (1975) 0.78

Postoperative limited volume irradiation in a child with a solitary brain metastasis from Wilms tumor: a case report. Med Pediatr Oncol (1997) 0.78

Occult nephroblastoma (Wilms' tumor) presenting with symptoms of central nervous system involvement. Acta Neurol (Napoli) (1979) 0.77